It is possible new templates exist for this target since these models were created.
Available Structures
8 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human PTPdelta and human Slitrk1 complex |
Heteromer Q96PX8; | 3×NAG; 1×SO4; | ||||
| Assess | ||||||
| Crystal structures of human SALM5 in complex with human PTPdelta |
Heteromer Q96NI6; | 8×NAG; 2×NA; 12×CA; 12×CL; 4×SO4; | ||||
| Assess | ||||||
| Crystal structure of PTP delta Ig1-Ig3 in complex with IL1RAPL1 Ig1-Ig3 |
Heteromer Q9NZN1; | 1×NAG; 3×NAG; 1×NAG; 2×NAG; 3×ZN; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Del… | homo-2-mer | 2×CL; 2×FLC; | ||||
| Assess | ||||||
| Crystal structure of the FN4-FN6 domains of human PTPRD | monomer | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Del… | monomer | 1×PO4; | ||||
| Assess | ||||||
| Solution structure of the second fn3 domain of human receptor-type tyrosine-protein phosphatase del… | monomer | |||||
| Assess | ||||||
| Solution structure of the fibronectin type-III domain of human protein tyrosine phosphatase, recept… | monomer | |||||
| Assess | ||||||
9 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3sr9.1.A | monomer | 0.84 | 90.10 | |||
| Assess | ||||||
| 4yfg.1.A | monomer | 0.73 | 98.13 | |||
| Assess | ||||||
| 4pbx.1.A | monomer | 0.72 | 72.55 | |||
| Assess | ||||||
| 4yh7.1.A | monomer | 0.68 | 95.90 | |||
| Assess | ||||||
| 4yh7.1.A | monomer | 0.60 | 92.43 | |||
| Assess | ||||||
| 8g4l.38.A | monomer | 0.53 | 22.44 | |||
| Assess | ||||||
| 8g4l.37.A | monomer | 0.52 | 22.44 | |||
| Assess | ||||||
| 8q6t.1.I | monomer | 0.52 | 19.06 | |||
| Assess | ||||||
| 8q6t.1.P | monomer | 0.52 | 19.06 | |||
| Assess | ||||||